Fig. 1From: Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor βCLDN4 promotes malignant behavior of the breast cancer cell lines T47D and MCF-7. A Western blot analysis showing the absence and presence of CLDN4 protein in the indicated cells. B–D Representative and quantitative BrdU assay for the indicated cells. The BrdU/DAPI levels are plotted and shown in the histograms (mean ± SD; n = 4). E–G Typical and quantitative wound healing assay of the indicated cells. The wound closure rates are plotted and shown in the histograms (mean ± SD; n = 8). Scale bars, 50 µm (B); 100 μm (E)Back to article page